Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 25, No. 3, 2003 (September)

Content

THE CLINICAL SIGNIFICANCE OF OCCULT HBV INFECTION IN ACUTE DELTA VIRUS HEPATITIS IN A CASE OF IMMUNOSUPPRESSIVE THERAPHY FOR NON-HOdGKIN’S LYMPHOMA

 

B. Palmentieri, P. Di Micco, G. Di Giacomo Russo, A. Morante, E. Persico, A. Niglio, R. Torella, M. Persico

Internal Medicine and Hepatology Unit, Second Univeristy of Naples, Naples, Italy

Abstract. Chemotherapy may induce virus B reactivation in patients carriers of HBsAg. The clinical significance of occult B virus (HbcAB positive patients) is still uncertain then it is not clear if chemotherapy may be dangerous also in the case of patients carriers of HBcAB. The evidence reported in this case report on one hand supports the idea of a significant role of occult B virus and on the other suggests the possibility that chemotherapy might be dangerous also in carriers of occult B virus.

Key Words: hepatitis B virus, HbcAB, HbsAg.

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster